{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:47:57Z","timestamp":1750942077648},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jacl.2012.11.005","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T18:42:47Z","timestamp":1354732967000},"page":"140-146","source":"Crossref","is-referenced-by-count":7,"title":["Apple pectin for the reduction of niacin-induced flushing"],"prefix":"10.1016","volume":"7","author":[{"given":"Patrick M.","family":"Moriarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Backes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie-Ann","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle F.","family":"Ruisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Schmelzle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2012.11.005_bib1","series-title":"Heart Disease and Stroke Statistics - 2005 Update","year":"2005"},{"key":"10.1016\/j.jacl.2012.11.005_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2012.11.005_bib3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2012.11.005_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3810\/pgm.2011.03.2265","article-title":"Important considerations for treatment with dietary supplement versus prescription niacin products","volume":"123","author":"Backes","year":"2011","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jacl.2012.11.005_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2012.11.005_bib6","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jacl.2012.11.005_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP45078","article-title":"Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation","volume":"45","author":"Cefali","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jacl.2012.11.005_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1368-5031.2006.00957.x","article-title":"Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment","volume":"60","author":"Oberwittler","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacl.2012.11.005_bib9","first-page":"292","article-title":"Effects of antihistamines on inflammatory mediators","volume":"71","author":"Naclerio","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jacl.2012.11.005_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2012.11.005_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjcard.2012.05.009","article-title":"Effectiveness and safety of laropiprant on niacin-induced flushing","volume":"110","author":"Maccubbin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2012.11.005_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1440-1681.2007.04706.x","article-title":"Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers","volume":"34","author":"Sanaka","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jacl.2012.11.005_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/10408399709527767","article-title":"Chemistry and uses of pectin\u2013a review","volume":"37","author":"Thakur","year":"1997","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jacl.2012.11.005_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0168-3659(94)90028-0","article-title":"Studies on pectin formulations for colonic drug delivery","volume":"30","author":"Ashford","year":"1994","journal-title":"J Control Release"},{"key":"10.1016\/j.jacl.2012.11.005_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10611869408996806","article-title":"Targeting drugs to the colon: delivery systems for oral administration","volume":"2","author":"Ashford","year":"1994","journal-title":"J Drug Target"},{"key":"10.1016\/j.jacl.2012.11.005_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ajcn\/48.6.1413","article-title":"Sustained pectin ingestion: effect on gastric emptying and glucose tolerance in non-insulin-dependent diabetic patients","volume":"48","author":"Schwartz","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2012.11.005_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0140-6736(79)91079-1","article-title":"Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol","volume":"1","author":"Holt","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2012.11.005_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/039463200802100304","article-title":"A quercetin containing supplement reduces niacin-induced flush in humans","volume":"21","author":"Kalogeromitros","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jacl.2012.11.005_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00044011-200929040-00001","article-title":"Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy","volume":"29","author":"Kawata","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacl.2012.11.005_bib20","unstructured":"Bender WA. U.S. Patent 3,485,920. 1969. Chem Abstr. 72:59069u,\u00a01970."},{"key":"10.1016\/j.jacl.2012.11.005_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5414\/CPP44633","article-title":"Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation","volume":"44","author":"Cefali","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jacl.2012.11.005_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacl.2009.04.005","article-title":"A single dose of extended-release niacin suppresses postprandial triglyceridemia in healthy volunteers","volume":"3","author":"Dunbar","year":"2009","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2012.11.005_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ejcn.2011.208","article-title":"Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women","volume":"66","author":"Brouns","year":"2012","journal-title":"Eur J Clinl Nutr"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412004114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412004114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T19:13:57Z","timestamp":1714677237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287412004114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1933287412004114"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2012.11.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}